Evidence map›Paper›PMID 35328746›Full record

ArticleInternational journal of molecular sciences2022

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.

Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, Jan Viehof, Ágnes Enyedi, Ágnes Bilecz, Balázs Győrffy, Marcell Baranyi, Anna-Mária Tőkés, Jeovanis Gil and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Novel Biomarkers and Therapeutic Targets for Melanoma.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Luca HegedüsDepartment of Thoracic Surgery, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany.
Elisabeth LivingstoneDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.ORCID 0000-0001-8279-9239
Ágnes BánkfalviDepartment of Pathology, University Medicine Essen, 45147 Essen, Germany.
Jan ViehofDepartment of Thoracic Surgery, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany.
Ágnes EnyediDepartment of Transfusiology, Semmelweis University, 1085 Budapest, Hungary.ORCID 0000-0002-7366-9376
Ágnes Bilecz2nd Department of Pathology, Semmelweis University, 1085 Budapest, Hungary.
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, 1085 Budapest, Hungary.
Marcell Baranyi2nd Department of Pathology, Semmelweis University, 1085 Budapest, Hungary.
Anna-Mária Tőkés2nd Department of Pathology, Semmelweis University, 1085 Budapest, Hungary.
Jeovanis GilDivision of Oncology, Department of Clinical Sciences Lund, Lund University, 221 00 Lund, Sweden.ORCID 0000-0003-3601-3893
György Marko-VargaClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, 221 00 Lund, Sweden.
Klaus G GriewankDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.ORCID 0000-0003-3899-9449
Lisa ZimmerDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.
Renáta VáraljaiDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.ORCID 0000-0001-6852-6859
Antje SuckerDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.
Anne ZarembaDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.
Dirk SchadendorfDepartment of Dermatology, University Medicine Essen, 45147 Essen, Germany.
Clemens AignerDepartment of Thoracic Surgery, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany.ORCID 0000-0002-7787-991X
Balázs HegedüsDepartment of Thoracic Surgery, University Medicine Essen-Ruhrlandklinik, 45239 Essen, Germany.ORCID 0000-0002-4341-4153
Essen University Hospital · DESemmelweis University · HURuhrlandklinik · DELund University · SE

Funding

Deutsche Forschungsgemeinschaft SCHA422/17-1Hungarian Scientific Research Fund K135811Hungarian Scientific Research Fund NKFI K119223Ministry for Innovation and Technology in Hungary 2020-1.1.6-JÖVŐ-2021-00013Ministry for Innovation and Technology in Hungary 2020-4.1.1.-TKP2020
6 · The paper itself

Abstract

PMCA4 is a critical regulator of Ca

Indexed as

MelanomaNevusSkin NeoplasmsAnimalsCutaneous Malignant MelanomaFemaleHumansImmune Checkpoint InhibitorsMammalsPlasma Membrane Calcium-Transporting ATPasesPrognosisProgrammed Cell Death 1 ReceptorRNA, MessengerImmune Checkpoint InhibitorsPlasma Membrane Calcium-Transporting ATPasesProgrammed Cell Death 1 ReceptorRNA, Messengerimmune checkpoint inhibitionlung metastasismelanomaplasma membrane calcium ATPase 4

Identifiers

PMID35328746
PMCPMC8949876
OpenAlexW4220949428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.